Revenue
2025
Medical Exercise Inc. (MDXR)
Price—Loading quote
Financial statements
| 2026 | 2025 | |
|---|---|---|
| Revenue | N/A | $1,294 |
| Gross profit | N/A | $849 |
| Gross margin | N/A | 65.61% |
| Operating expenses | $222,363 | $332,223 |
| Operating income | −$222,363 | −$331,374 |
| Operating margin | N/A | −25,608.50% |
| EBITDA | −$213,627 | −$319,882 |
| EBITDA margin | N/A | −24,720.40% |
| Net income | −$226,708 | −$330,985 |
| Net profit margin | N/A | −25,578.44% |
| Basic EPSper basic share | -$0.02 | -$0.03 |
| Diluted EPSper diluted share | -$0.02 | -$0.03 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Degelman Matthew John | 1M |
LEMOS MAX MAGALHAES | 1M |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 3 ↗Updated Oct 21, 2026 · Quarterly data